BIO
ConsumerValuation Breakdown
A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.
Valuation Track Record
Retroactive intrinsic value vs actual close price — BIO
Earnings Quality
Fiscal year 2025
Financial Forensics
Beneish M-Score · 2025
The Beneish M-Score of -2.1804 indicates that BIO is not likely to be manipulating earnings, as it is below the threshold of -1.78. However, the low revenue quality score of 10.4/100 raises concerns about the sustainability of reported revenues, which could pose risks in the Vietnamese market context.
- Low revenue quality score of 10.4/100 suggests potential issues with revenue recognition.
- High concentration of ownership with Lê Đình Phan holding 39.0% may lead to governance risks and lack of minority shareholder protection.
- Beneish M-Score of -2.1804 indicates a low likelihood of earnings manipulation.
- Strong accrual quality score of 94.8/100 reflects good earnings quality in terms of accruals.
The top three shareholders collectively hold 85% of the company, which poses significant risks to minority shareholders regarding decision-making and potential conflicts of interest.
Investors should closely monitor revenue recognition practices and consider the implications of concentrated ownership before making investment decisions. A deeper analysis of cash flow and revenue sustainability is recommended.
Generated by AI based on quantitative data. Not financial advice.
Quantitative Scores
Key Ratios
Company Overview
// OWNERSHIP_NETWORK
> mapping common ownership for BIO — hover nodes for intel, click to navigate